Skip to main contentSkip to navigationSkip to search

UN's sustainable development goals (SDG) analys

Camurus and the UN’s Sustainable Development Goals
Camurus’ sustainability work aims to contribute to the UN’s Sustainable
Development Goals (SDGs). Of the UN’s 17 SDGs, Camurus has identified
nine where the company sees the greatest potential for a positive impact.

The table below shows how Camurus is contributing to the respecive selected SDGs. 

SDG3. Good health and well-being: Ensure healthy lives and promote well-being for all at all ages
3.5 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
 Camurus' contribution: Opioid dependence is a serious, chronic, and relapsing disease that affects all aspects of a person’s life. It is also an escalating global health problem, contributing to significant negative consequences such as unemployment, criminal activity, imprisonment, transmission of infectious diseases, unintentional overdoses, and death. Opioid dependence is often associated with high social stigma and social exclusion. Camurus provides an opioid dependence treatment with demonstrated improved patient-reported outcomes, including higher treatment satisfaction, reduced treatment burden, and improved quality of life for patients with Buvidal compared to daily standard treatment.1-3
 Camurus goal: Reach 100,000 patients in treatment with Buvidal® during 2026
Target:3.8 Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all
 Camurus' contribution: Camurus' long acting medicines for treatment of severe and chronic diseases aim to create significant benefits for patients, caregivers, healthcare systems and society. By increasing the access to Camurus' medicines more people can be helped in attaining both better health and quality of life.
An important step to increase access to treatment is to raise disease awareness and reduce potential stigma for those affected. In an effort to address this, Camurus supports and collaborates with healthcare and patient organizations to increase knowledge about serious and rare diseases. This work is conducted within the framework of the EFPIA (European Federation of Pharmaceutical Industries and Associations) guidelines and Camurus Healthcare Compliance program.The proper promotion and scientific exchange concerning Camurus products, as well as education about diseases and their management, adds important knowledge to the healthcare community, and is essential to ensure that as many patients as possible can have access to evidence based and qualitative care. Camurus' program, which includes our Healthcare Interactions Policy, procedures, guidelines, tools and training, is designed to ensure that all promotion and other information exchange is made in full compliance with regulations, laws, ethics and industry codes.
SDG:5. Gender Equality: Achieve gender equality and empower all women and girls
5.5 Ensure women’s full and effective participation and equal opportunities for leadership at all levels of decision-making in political, economic and public life
 Camurus' contribution: 
Camurus actively pursues diversity, equity and inclusion (DEI) work and strives for an equal gender distribution.
Current gender distribution: 
  • amongst total number of employees: 67% women, 33% men
  • at management level: 46% women, 54% men
  • at executive leadership group level: 30% women, 70% men
  • at board level: 44 % women, 56% men
Camurus' goal:
Gender distribution at Board and management level must in 2026 reflect the company as a whole (±20%)
SDG:6. Ensure availability and sustainable management of water and sanitation for all
6.3 By 2030, improve water quality by reducing pollution, eliminating dumping and minimizing release of hazardous chemicals and materials, halving the proportion of untreated wastewater and substantially increasing recycling and safe reuse globally
 Camurus' contribution: Camurus is committed to use water efficiently and to prevent all releases of chemicals or pharmaceuticals into water, soil or air. Both within Camurus' own operations and within the outsourced manufacturing of products procedures are in place to prevent the release of chemicals or other polluting substances e.g. active pharmaceutical ingredient (API) or exipients to water. All process water (from production and lab) is collected and sent for destruction.
7. Ensure access to affordable, reliable, sustainable and modern energy for all
Target:7.2 By 2030, increase substantially the share of renewable energy in the global energy mix
 Camurus' contribution: Camurus is committed to using renewable energy and reducing its energy footprint throughout the value chain.
Camurus procures renewable energy to the greatest extent possible in its own operations and challenges its vendors to use renewable energy. Actual share of renewble energy within own operations is 95%.
Camurus' goal:

From 2024 onwards, at least 80% of the energy used within Camurus’ operations to come from renewable sources

8. Decent work and economic growth: Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all
8.8 Protect labour rights and promote safe and secure working environments for all workers, including migrant workers,in particular women migrants, and those in precarious employment
 Camurus' contribution: 
Camurus' employees are Camurus' greatest asset. Camurus works actively to provide a sound and developing working environment that protects both the human rights and labor rights of all employees. Camurus actively pursues DEI work (diversity, equity and inclusion), and considers occupational health and safety work of critical importance. A majority of Camurus' employees are covered by collecting bargaining agreements.
Given that global and complex supply chains often offer limited control and transparency, they can contain the risk of violations of human rights and labor rights, unsecure working environments, and discrimination. Camurus' vendors are required to comply with Camurus' Vendor Code of Conduct which challenges them to meet Camurus' sustainability standards, which include, amongst other things respect for human rights, labor rights, and the provision of decent working conditions. Camurus evaluates its vendors' compliance with the code and works actively together with its vendors to prevent and minimize sustainability risks within the supply chains.
Camurus' goal:

Healthy attendance over 97% in 2026

SDG:10. Reduce inequalities within and among countries
10.2 By 2030, empower and promote the social, economic and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion or economic or other status
 Camurus' contribution: Camurus works actively to improve access to treatment of opioid dependence and reduce stigma for people with opioid dependence, increasing the opportunity for everyone, regardless of socio-economic background, to participate in society on equal terms
Camurus' goal 2026:Conduct annual projects focused on reducing stigma for patients
SDG:12. Responsible consumption and production: Ensure sustainable consumption and production patterns.
12.2 By 2030, achieve the sustainable management and efficient use of natural resources
 Camurus' contribution: Camurus har åtagit sig att använda resurser effektivt, att bidra till cirkularitet och att förebygga och minimera både föroreningar och utsläpp. Camurus långverkande FluidCrystal-teknologi utnyttjar både aktiv läkemedelsingrediens (API) och hjälpämnen effektivt jämfört med andra tillgängliga läkemedel t.ex. bufrenorfin sublinguala tabletter. Camurus och dess tillverkare av produkter arbetar aktivt för att använda vatten effektivt och att återanvända vatten där det är möjligt. Camurus utvärderar också sina leverantörers vatten- och resurshantering och uppmana till resurseffektivitet. Dessutom strävar Camurus efter att använda råvaror och energi så effektivt som möjligt både i sin egen verksamhet och i den utkontrakterade tillverkningsprocessen. Camurus egen verksamhet använder en hög andel förnybar energi och Camurus arbetar aktivt med att fasa in förnybar energi i transporterna. För att säkerställa produkt- och patientsäkerhet är läkemedelsindustrin hårt reglerad och resursanvändningen inom vissa områden är relativt hög t.ex. när det gäller förpackningar och produkttransporter. Idag används delvis förnybart och återvunnet förpackningsmaterial och företaget arbetar med att minska miljöpåverkan från både förpackningar och produkttransporter. 
Target:12.5 By 2030, substantially reduce waste generation through prevention, reduction, recycling and reuse 
 Camurus' contribution: Camurus is commited to preventing and reducing all kinds of waste (including hazardous waste). Both in Camurus' own operations and in manufacturing there is a waste management system in place for management and recycling of waste including hazardous waste. Camurus also evaluates its vendors' waste management and encourages structured waste management with focus on preventing and minimizing waste of all types.
13. Climate action: Take urgent action to combat climate change and its impacts
13.1 Strengthen resilience and adaptive capacity to climate-related hazards and natural disasters in all countries
13.3 Improve education, awareness-raising and human and institutional capacity on climate change mitigation, adaptation, impact reduction and early warning
 Camurus' contribution: 
Camurus is commited to protecting the environment and proactively preventing and mitigating environmental pollution, including greenhouse gas emissions. Camurus works strategically to reduce its carbon footprint and increase climate adaptation throughout the value chain. Engagement of employees and vendors is key in this work. All employees receive training on the topic of sustainability which includes Camurus' environmental and sustainability policies and the company's carbon footprint reduction work. Camurus has set goals and developed an action plan to increase the share of renewable energy and achieve the transition to climate neutrality. All employees are delegated the responsibility to actively participate in Camurus' environmental and sustainability work. Camurus also collaborates with its vendors to reduce both carbon emissions, and other environmental footprints, and ultimately increase climate adaptation throughout the value chain.
Camurus' goal:
  • Reduce scope 1 and 2 greenhouse gas emissions by at least 50% by 2035 (compared to 2023 levels)
  • Reduce selected scope 3 greenhouse gas emissions by at least 40% by 2035 (compared to 2023 levels)
  • Net zero greenhouse gas emissions (scope 1, 2 and 3) by 2045
  • Transition from combustion engine cars to electric cars should be conducted as fast as possible
  • From 2024 all new benefit cars are electric cars where technically feasible: Transition of job cars to electric cars in the Nordic countries by 2030 where technically feasible; Transition of job cars to electric cars in other European countries by 2035 where technically feasible; Transition of job cars to electric cars in all other countries by 2040
SDG:16. Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels
Target:16.5 Substantially reduce corruption and bribery in all their forms
 Camurus' contribution: Camurus' Business Ethics and Compliance Framework, which includes policies, procedures, controls and governance mechanisms, is designed to detect, prevent and address bribery and other forms of corruption. The framework is applied across the operations, with particular focus on measures that mitigate those risks in relation to the interactions with Camurus customers and other healthcare stakeholders, including interactions performed by Third Parties on Camurus' behalf. The framework is continously strengthened, through expanded policies, controls and training. These ensure oversight and monitoring of activities in the business, build ownership and awareness for ethics and compliance in the organization, and lower the resistance to raising difficult questions and reporting concerns.
Camurus' goal:
  • Annual training of all Camurus employees and consultants in the company's Code of Conduct in relevant topics, such as anti-corruption and data protection
  • Ensure an open culture where employees feel safe to report suspected misconduct, including corruption, as well as a robust framework for monitoring andauditing within which any problems are identified and addressed 
  • Disclose for value transfers to the healthcare system according to applicable industry codes or on a voluntary basis
  • Monitor all suppliers in the first tier within research and development, production and distribution regarding compliance with Camurus’ Vendor Code of Conduct


  1. Lofwall MR, et al. JAMA Intern Med. 2018;178(6);764–773.
  2. Lintzeris N., et al. JAMA Network Open. 2021;4(5):e219041.
  3. Frost M., et al. Addiction. 2019;114:1416–1426.